Ming Cheng

Title: The Innovations of Inventor Ming Cheng

Introduction

Ming Cheng is an accomplished inventor based in Ridgefield, CT (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies. His work focuses on addressing critical health issues, including cancer treatment.

Latest Patents

Ming Cheng holds a patent for "Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof." This patent describes antibodies that specifically bind to chondroitin sulfate proteoglycan 4 (CSPG4). It includes chimeric and humanized anti-CSPG4 antibodies and their fragments. The patent also outlines methods for using these antibodies in the detection, prevention, and therapeutic treatment of CSPG4-related diseases, particularly melanoma.

Career Highlights

Throughout his career, Ming Cheng has worked with prestigious institutions such as Memorial Sloan Kettering Cancer Center and The General Hospital Corporation. His research has contributed to advancements in cancer therapies and has had a significant impact on the medical community.

Collaborations

Ming Cheng has collaborated with notable professionals in his field, including Soldano Ferrone and Nai-Kong V Cheung. These collaborations have further enhanced his research and development efforts.

Conclusion

Ming Cheng's innovative work in the field of therapeutic antibodies showcases his dedication to improving cancer treatment. His contributions through patents and collaborations highlight the importance of research in advancing medical science.